肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

Eph受体和ephrin在癌症进展中的作用

Eph receptors and ephrins in cancer progression

原文发布日期:2023-11-23

DOI: 10.1038/s41568-023-00634-x

类型: Review Article

开放获取: 否

英文摘要:

摘要翻译: 

原文链接:

文章:

Eph受体和ephrin在癌症进展中的作用

Eph receptors and ephrins in cancer progression

原文发布日期:2023-11-23

DOI: 10.1038/s41568-023-00634-x

类型: Review Article

开放获取: 否

 

英文摘要:

Evidence implicating Eph receptor tyrosine kinases and their ephrin ligands (that together make up the ‘Eph system’) in cancer development and progression has been accumulating since the discovery of the first Eph receptor approximately 35 years ago. Advances in the past decade and a half have considerably increased the understanding of Eph receptor–ephrin signalling mechanisms in cancer and have uncovered intriguing new roles in cancer progression and drug resistance. This Review focuses mainly on these more recent developments. I provide an update on the different mechanisms of Eph receptor–ephrin-mediated cell–cell communication and cell autonomous signalling, as well as on the interplay of the Eph system with other signalling systems. I further discuss recent advances in elucidating how the Eph system controls tumour expansion, invasiveness and metastasis, supports cancer stem cells, and drives therapy resistance. In addition to functioning within cancer cells, the Eph system also mediates the reciprocal communication between cancer cells and cells of the tumour microenvironment. The involvement of the Eph system in tumour angiogenesis is well established, but recent findings also demonstrate roles in immune cells, cancer-associated fibroblasts and the extracellular matrix. Lastly, I discuss strategies under evaluation for therapeutic targeting of Eph receptors–ephrins in cancer and conclude with an outlook on promising future research directions.

 

摘要翻译: 

自大约35年前首次发现Eph受体以来,越来越多的证据表明Eph受体酪氨酸激酶及其配体ephrin(共同构成“Eph系统”)参与癌症的发生发展。过去十五年的研究进展极大增进了我们对Eph受体-ephrin在癌症中信号传导机制的理解,并揭示了其在癌症进展和耐药性方面令人关注的新功能。本综述主要聚焦于这些最新研究进展,重点阐述Eph受体-ephrin介导的细胞间通讯与细胞自主信号传导机制,以及Eph系统与其他信号系统的相互作用。同时探讨Eph系统如何调控肿瘤扩张、侵袭与转移、维持癌症干细胞特性及驱动治疗耐药性的最新发现。除在癌细胞内部发挥作用外,Eph系统还介导癌细胞与肿瘤微环境细胞的双向通讯。该系统在肿瘤血管生成中的作用已明确,而最新研究还揭示了其在免疫细胞、癌症相关成纤维细胞和细胞外基质中的功能。最后,本文讨论了目前正在评估的Eph受体-ephrin靶向治疗策略,并对未来具有前景的研究方向进行展望。

 

原文链接:

Eph receptors and ephrins in cancer progression

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……